These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33496472)

  • 1. Implications of Pathologic Findings in Cytoreductive Surgery Specimens on Treatment of Colorectal Peritoneal Metastases: Results of a Prospective Multicentric Study.
    Bhatt A; Benzerdjeb N; Passot G; Kammar P; Mehta S; Laplace N; Cotte E; Glehen O
    Dis Colon Rectum; 2021 May; 64(5):534-544. PubMed ID: 33496472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Omental Metastases in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases.
    Bonnefoy I; Mohamed F; Bonnot PE; Benzerdjeb N; Isaac S; Cotte E; Glehen O; Passot G
    Dis Colon Rectum; 2020 Sep; 63(9):1251-1256. PubMed ID: 32618618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years.
    Ghabra S; Desale S; Sugarbaker PH
    Dis Colon Rectum; 2023 Oct; 66(10):1329-1338. PubMed ID: 36856661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Pathologic Complete Response for Rectal Cancer Based on Pretreatment Factors Using Machine Learning.
    Chen KA; Goffredo P; Butler LR; Joisa CU; Guillem JG; Gomez SM; Kapadia MR
    Dis Colon Rectum; 2024 Mar; 67(3):387-397. PubMed ID: 37994445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases.
    Hofste LSM; Geerlings MJ; Kamping EJ; Kouwenhoven NDH; von Rhein D; Jansen EAM; Garms LM; Nagtegaal ID; van der Post RS; de Wilt JHW; Klarenbeek BR; Ligtenberg MJL
    Dis Colon Rectum; 2023 Jun; 66(6):796-804. PubMed ID: 35857852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei.
    Shariff US; Chandrakumaran K; Dayal S; Mohamed F; Cecil TD; Moran BJ
    Dis Colon Rectum; 2020 Sep; 63(9):1257-1264. PubMed ID: 33216496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal Cancer.
    Ishioka M; Chino A; Ide D; Saito S; Igarashi M; Nagasaki T; Akiyoshi T; Nagayama S; Fukunaga Y; Ueno M; Kawachi H; Yamamoto N; Fujisaki J; Konishi T
    Dis Colon Rectum; 2021 Jan; 64(1):53-59. PubMed ID: 32639283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
    Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
    Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
    Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
    Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China.
    Yao H; An Y; Zhang H; Ren M; Chen CC; Xu Q; Wang Q; Zhang Z;
    Dis Colon Rectum; 2021 Feb; 64(2):190-199. PubMed ID: 33395134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Indocyanine Green Fluorescence Imaging Assessment for Nonmucinous Peritoneal Metastases: Preliminary Results of the ICCP Study.
    González-Abós C; Selva AB; de Lacy FB; Valverde S; Almenara R; Lacy AM
    Dis Colon Rectum; 2022 Mar; 65(3):314-321. PubMed ID: 34775406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.